UH

Uwe Hurth

Active Director Director DIN 07900128
DIN 07900128 First appointment Dec 2017 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Dec 2017
Shareholding value Locked Premium profile

About Uwe Hurth

Uwe Hurth has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Ursapharm India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07900128
Primary Designation Director
First Appointment 05 Dec 2017
Oldest Company Age 19 yrs

Current companies

Company Designation Appointment Founded Status
Ursapharm India Private Limited U24232DL2006FTC154392
Director 05 Dec 2017 2006 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ursapharm India Private Limited
Premium access

Shareholding and investment profile for Uwe Hurth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uwe Hurth

Uwe Hurth has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Ursapharm India Private Limited. Engaged in General Business. Contributes to corporate operations.

Uwe Hurth is associated with 1 company as Director.

Uwe Hurth has expertise in General Business.

Uwe Hurth has 8 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available